Telangana sets up panel to approve use of Tocilizumab for cr

Telangana sets up panel to approve use of Tocilizumab for critical COVID-19 patients


Telangana sets up panel to approve use of Tocilizumab for critical COVID-19 patients
Tocilizumab is one of the treatment options being used by hospitals to help COVID-19 patients in light of the fact that the other commonly used drug Remdesivir is out of stock
Share Via Email
  |  A+A A-
By Express News Service
HYDERABAD: The Telangana government has set up a three-member committee to look into the allocation of the drug Tocilizumab for critical ICU patients.
On Friday, the health department issued a memo stating that the government has constituted the committee for allocation of Tocilizumab to COVID-19 patients in both government and private hospitals in the state. The members would be the Director, Nizams Institute of Medical Sciences, Director of Medical Education and Director of Public Health and Family Welfare.

Related Keywords

Hyderabad , Andhra Pradesh , India , Telangana , , Public Health , News Service , Nizams Institute Of Medical Sciences , Express News , Nizams Institute , Medical Sciences , Medical Education , Covid 19 , Coronavirus , Tocilizumab , ஹைதராபாத் , ஆந்திரா பிரதேஷ் , இந்தியா , தெலுங்கானா , பொது ஆரோக்கியம் , செய்தி சேவை , நிஜாம்கள் நிறுவனம் ஆஃப் மருத்துவ அறிவியல் , எக்ஸ்பிரஸ் செய்தி , நிஜாம்கள் நிறுவனம் , மருத்துவ அறிவியல் , மருத்துவ கல்வி , விட் ,

© 2025 Vimarsana